ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Insulin API Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-14L12146
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Insulin API Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028
BUY CHAPTERS

Global Insulin API Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-14L12146
Report
June 2025
Pages:154
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novo Nordisk
Sanofi Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon Ltd.
Amphastar
WOCKHARDT
Julphar Diabetes
Torrent Pharma

Insulin API Market Size

In 2024, the global market size of Insulin API was estimated to be worth US$ 1848 million and is forecast to reach approximately US$ 2250 million by 2031 with a CAGR of 2.9% during the forecast period 2025-2031.

Insulin API Market

Insulin API Market

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.
In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.
The major players in global Insulin API market include Novo Nordisk, Sanofi-Aventis, etc. The top 2 players occupy over 65% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Insulin Analogue is the main market, and occupies about 90% of the global market. Long-Acting is the main type, with a share over 40%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Insulin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin API.
The Insulin API market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Insulin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insulin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Insulin API Market Report

Report Metric Details
Report Name Insulin API Market
Forecasted market size in 2031 approximately US$ 2250 million
CAGR 2.9%
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Fast-Acting
  • Premix
  • Long-Acting
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novo Nordisk, Sanofi-Aventis, Eli Lilly, Tonghua Dongbao, Ganlee, United Laboratory, Biocon, Amphastar, Wockhardt, Julphar Diabetes, Torrent Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Insulin API in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Insulin API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Insulin API sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Insulin API Market size in 2031?

Ans: The Insulin API Market size in 2031 will be approximately US$ 2250 million.

What is the market share of major companies in Insulin API Market?

Ans: The top 2 players occupy over 65% shares of the global market.

What is the Insulin API Market share by type?

Ans: Insulin Analogue is the main market, and occupies about 90% of the global market.

What is the Insulin API Market share by application?

Ans: Long-Acting is the main type, with a share over 40%.

Who are the main players in the Insulin API Market report?

Ans: The main players in the Insulin API Market are Novo Nordisk, Sanofi-Aventis, Eli Lilly, Tonghua Dongbao, Ganlee, United Laboratory, Biocon, Amphastar, Wockhardt, Julphar Diabetes, Torrent Pharma

What are the Application segmentation covered in the Insulin API Market report?

Ans: The Applications covered in the Insulin API Market report are Fast-Acting, Premix, Long-Acting

What are the Type segmentation covered in the Insulin API Market report?

Ans: The Types covered in the Insulin API Market report are Regular Human Insulin, Insulin Analogue

Recommended Reports

Insulin Delivery Devices

API Market Trends

Insulin Types & Therapy

1 Study Coverage
1.1 Insulin API Product Introduction
1.2 Market by Type
1.2.1 Global Insulin API Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Regular Human Insulin
1.2.3 Insulin Analogue
1.3 Market by Application
1.3.1 Global Insulin API Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Fast-Acting
1.3.3 Premix
1.3.4 Long-Acting
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Insulin API Market Size Estimates and Forecasts
2.1.1 Global Insulin API Revenue 2020-2031
2.1.2 Global Insulin API Sales 2020-2031
2.2 Insulin API Market Size by Region: 2024 Versus 2031
2.3 Insulin API Sales by Region (2020-2031)
2.3.1 Global Insulin API Sales by Region: 2020-2025
2.3.2 Global Insulin API Sales Forecast by Region (2026-2031)
2.3.3 Global Insulin API Sales Market Share by Region (2020-2031)
2.4 Insulin API Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Insulin API Revenue by Region: 2020-2025
2.4.2 Global Insulin API Revenue Forecast by Region (2026-2031)
2.4.3 Global Insulin API Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Insulin API Sales by Type (2020-2031)
3.1.1.1 Global Insulin API Sales Volume by Type (2020-2031)
3.1.1.2 Global Insulin API Sales Market Share by Type (2020-2031)
3.1.2 Global Insulin API Revenue by Type (2020-2031)
3.1.2.1 Global Insulin API Revenue by Type (2020-2031)
3.1.2.2 Global Insulin API Revenue Market Share by Type (2020-2031)
3.1.3 Insulin API Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Insulin API Sales by Application (2020-2031)
3.2.1.1 Global Insulin API Sales Volume by Application (2020-2031)
3.2.1.2 Global Insulin API Sales Market Share by Application (2020-2031)
3.2.2 Global Insulin API Revenue by Application (2020-2031)
3.2.2.1 Global Insulin API Revenue by Application (2020-2031)
3.2.2.2 Global Insulin API Revenue Market Share by Application (2020-2031)
3.2.3 Insulin API Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Regular Human Insulin of Insulin API Revenue Market Share by Application
3.3.2 Insulin Analogue of Insulin API Revenue Market Share by Application
4 Global Insulin API by Manufacturers
4.1 Global Top Insulin API Manufacturers by Sales (2020-2025)
4.1.1 Global Insulin API Sales by Manufacturer (2020-2025)
4.1.2 Global Insulin API Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Insulin API Manufacturers by Revenue (2020-2025)
4.2.1 Global Insulin API Revenue by Manufacturer (2020-2025)
4.2.2 Global Insulin API Revenue Share by Manufacturer (2020-2025)
4.3 Global Insulin API Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Insulin API Manufacturers Covered: Ranking by Revenue
4.4.2 Global Insulin API Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Insulin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Insulin API Manufacturing Base Distribution, Product Type
4.5.1 Insulin API Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Insulin API Market
4.5.3 Manufacturers Insulin API Product Type and Application
4.5.4 Regular Human Insulin Market Sales of Insulin API by Manufacturer
4.5.5 Insulin Analogue Market Sales of Insulin API by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Novo Nordisk
5.1.1 Novo Nordisk Company Information
5.1.2 Novo Nordisk Description, Business Overview
5.1.3 Novo Nordisk Insulin API Products Offered
5.1.4 Novo Nordisk Insulin API Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Novo Nordisk Insulin API Sales by Product in 2024
5.1.6 Novo Nordisk Insulin API Sales by Application in 2024
5.1.7 Novo Nordisk Insulin API Sales by Geographic Area in 2024
5.1.8 Novo Nordisk Recent Developments
5.2 Sanofi-Aventis
5.2.1 Sanofi-Aventis Company Information
5.2.2 Sanofi-Aventis Description, Business Overview
5.2.3 Sanofi-Aventis Insulin API Products Offered
5.2.4 Sanofi-Aventis Insulin API Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Sanofi-Aventis Insulin API Sales by Product in 2024
5.2.6 Sanofi-Aventis Insulin API Sales by Application in 2024
5.2.7 Sanofi-Aventis Insulin API Sales by Geographic Area in 2024
5.2.8 Sanofi-Aventis Recent Developments
5.3 Eli Lilly
5.3.1 Eli Lilly Company Information
5.3.2 Eli Lilly Description, Business Overview
5.3.3 Eli Lilly Insulin API Products Offered
5.3.4 Eli Lilly Insulin API Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Eli Lilly Insulin API Sales by Product in 2024
5.3.6 Eli Lilly Insulin API Sales by Application in 2024
5.3.7 Eli Lilly Insulin API Sales by Geographic Area in 2024
5.3.8 Eli Lilly Recent Developments
5.4 Tonghua Dongbao
5.4.1 Tonghua Dongbao Company Information
5.4.2 Tonghua Dongbao Description, Business Overview
5.4.3 Tonghua Dongbao Insulin API Products Offered
5.4.4 Tonghua Dongbao Insulin API Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Tonghua Dongbao Insulin API Sales by Product in 2024
5.4.6 Tonghua Dongbao Insulin API Sales by Application in 2024
5.4.7 Tonghua Dongbao Insulin API Sales by Geographic Area in 2024
5.4.8 Tonghua Dongbao Recent Developments
5.5 Ganlee
5.5.1 Ganlee Company Information
5.5.2 Ganlee Description, Business Overview
5.5.3 Ganlee Insulin API Products Offered
5.5.4 Ganlee Insulin API Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Ganlee Insulin API Sales by Product in 2024
5.5.6 Ganlee Insulin API Sales by Application in 2024
5.5.7 Ganlee Insulin API Sales by Geographic Area in 2024
5.5.8 Ganlee Recent Developments
5.6 United Laboratory
5.6.1 United Laboratory Company Information
5.6.2 United Laboratory Description, Business Overview
5.6.3 United Laboratory Insulin API Products Offered
5.6.4 United Laboratory Insulin API Sales, Revenue and Gross Margin (2020-2025)
5.6.5 United Laboratory Insulin API Sales by Product in 2024
5.6.6 United Laboratory Insulin API Sales by Application in 2024
5.6.7 United Laboratory Insulin API Sales by Geographic Area in 2024
5.6.8 United Laboratory Recent Developments
5.7 Biocon
5.7.1 Biocon Company Information
5.7.2 Biocon Description, Business Overview
5.7.3 Biocon Insulin API Products Offered
5.7.4 Biocon Insulin API Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Biocon Insulin API Sales by Product in 2024
5.7.6 Biocon Insulin API Sales by Application in 2024
5.7.7 Biocon Insulin API Sales by Geographic Area in 2024
5.7.8 Biocon Recent Developments
5.8 Amphastar
5.8.1 Amphastar Company Information
5.8.2 Amphastar Description, Business Overview
5.8.3 Amphastar Insulin API Products Offered
5.8.4 Amphastar Insulin API Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Amphastar Insulin API Sales by Product in 2024
5.8.6 Amphastar Insulin API Sales by Application in 2024
5.8.7 Amphastar Insulin API Sales by Geographic Area in 2024
5.8.8 Amphastar Recent Developments
5.9 Wockhardt
5.9.1 Wockhardt Company Information
5.9.2 Wockhardt Description, Business Overview
5.9.3 Wockhardt Insulin API Products Offered
5.9.4 Wockhardt Insulin API Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Wockhardt Insulin API Sales by Product in 2024
5.9.6 Wockhardt Insulin API Sales by Application in 2024
5.9.7 Wockhardt Insulin API Sales by Geographic Area in 2024
5.9.8 Wockhardt Recent Developments
5.10 Julphar Diabetes
5.10.1 Julphar Diabetes Company Information
5.10.2 Julphar Diabetes Description, Business Overview
5.10.3 Julphar Diabetes Insulin API Products Offered
5.10.4 Julphar Diabetes Insulin API Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Julphar Diabetes Insulin API Sales by Product in 2024
5.10.6 Julphar Diabetes Insulin API Sales by Application in 2024
5.10.7 Julphar Diabetes Insulin API Sales by Geographic Area in 2024
5.10.8 Julphar Diabetes Recent Developments
5.11 Torrent Pharma
5.11.1 Torrent Pharma Company Information
5.11.2 Torrent Pharma Description, Business Overview
5.11.3 Torrent Pharma Insulin API Products Offered
5.11.4 Torrent Pharma Insulin API Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Torrent Pharma Insulin API Sales by Product in 2024
5.11.6 Torrent Pharma Insulin API Sales by Application in 2024
5.11.7 Torrent Pharma Insulin API Sales by Geographic Area in 2024
5.11.8 Torrent Pharma Recent Developments
6 North America
6.1 North America Insulin API Market Size YoY Growth 2020-2031
6.2 North America Insulin API Market Facts & Figures by Country
6.2.1 North America Insulin API Sales by Country (2020-2031)
6.2.2 North America Insulin API Revenue by Country (2020-2031)
6.3 North America Insulin API Sales by Type (2020-2025)
6.4 North America Insulin API Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Insulin API Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Insulin API Market Facts & Figures by Region
7.2.1 Asia-Pacific Insulin API Sales by Region (2020-2031)
7.2.2 Asia-Pacific Insulin API Revenue by Region (2020-2031)
7.3 Asia-Pacific Insulin API Sales by Type (2020-2025)
7.4 Asia-Pacific Insulin API Sales by Application (2020-2025)
8 Europe
8.1 Europe Insulin API Market Size YoY Growth 2020-2031
8.2 Europe Insulin API Market Facts & Figures by Country
8.2.1 Europe Insulin API Sales by Country (2020-2031)
8.2.2 Europe Insulin API Revenue by Country (2020-2031)
8.3 Europe Insulin API Sales by Type (2020-2025)
8.4 Europe Insulin API Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Insulin API Market Size YoY Growth 2020-2031
9.2 Latin America Insulin API Market Facts & Figures by Country
9.2.1 Latin America Insulin API Sales by Country (2020-2031)
9.2.2 Latin America Insulin API Revenue by Country (2020-2031)
9.3 Latin America Insulin API Sales by Type (2020-2025)
9.4 Latin America Insulin API Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Insulin API Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Insulin API Market Facts & Figures by Country
10.2.1 Middle East and Africa Insulin API Sales by Country (2020-2031)
10.2.2 Middle East and Africa Insulin API Revenue by Country (2020-2031)
10.3 Middle East and Africa Insulin API Sales by Type (2020-2025)
10.4 Middle East and Africa Insulin API Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Insulin API Supply Chain Analysis
11.2 Insulin API Key Raw Materials and Upstream Suppliers
11.3 Insulin API Clients Analysis
11.4 Insulin API Sales Channel and Sales Model Analysis
11.4.1 Insulin API Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Insulin API Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Insulin API Distributors
12 Insulin API Market Dynamics
12.1 Insulin API Industry Trends
12.2 Insulin API Market Drivers
12.3 Insulin API Market Challenges
12.4 Insulin API Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Novo Nordisk
Sanofi Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon Ltd.
Amphastar
WOCKHARDT
Julphar Diabetes
Torrent Pharma
List of Tables
 Table 1. Global Insulin API Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Insulin API Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Insulin API Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Insulin API Sales by Region (2020-2025) & (K Units)
 Table 5. Global Insulin API Sales Forecast by Region (2026-2031) & (K Units)
 Table 6. Global Insulin API Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Insulin API Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Insulin API Sales Volume by Type (2020-2025) & (K Units)
 Table 9. Global Insulin API Sales Volume by Type (2026-2031) & (K Units)
 Table 10. Global Insulin API Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Insulin API Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Insulin API Sales Volume by Application (2020-2025) & (K Units)
 Table 13. Global Insulin API Sales Volume by Application (2026-2031) & (K Units)
 Table 14. Global Insulin API Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Insulin API Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Insulin API Sales by Manufacturer (2020-2025) & (K Units)
 Table 17. Global Insulin API Sales Share by Manufacturer (2020-2025)
 Table 18. Insulin API Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Insulin API Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Insulin API Price (2020-2025) & (USD/Unit)
 Table 21. Ranking of Global Top Insulin API Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Insulin API Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Insulin API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin API as of 2024)
 Table 24. Insulin API Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Insulin API Market
 Table 26. Manufacturers Insulin API Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Novo Nordisk Company Information
 Table 29. Novo Nordisk Description and Business Overview
 Table 30. Novo Nordisk Insulin API Product
 Table 31. Novo Nordisk Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 32. Novo Nordisk Sales Proportion of Insulin API by Product in 2024
 Table 33. Novo Nordisk Sales Proportion of Insulin API by Application in 2024
 Table 34. Novo Nordisk Sales Proportion of Insulin API by Geographic Area in 2024
 Table 35. Novo Nordisk Recent Developments
 Table 36. Sanofi-Aventis Company Information
 Table 37. Sanofi-Aventis Description and Business Overview
 Table 38. Sanofi-Aventis Insulin API Product
 Table 39. Sanofi-Aventis Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 40. Sanofi-Aventis Sales Proportion of Insulin API by Product in 2024
 Table 41. Sanofi-Aventis Sales Proportion of Insulin API by Application in 2024
 Table 42. Sanofi-Aventis Sales Proportion of Insulin API by Geographic Area in 2024
 Table 43. Sanofi-Aventis Recent Developments
 Table 44. Eli Lilly Company Information
 Table 45. Eli Lilly Description and Business Overview
 Table 46. Eli Lilly Insulin API Product
 Table 47. Eli Lilly Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 48. Eli Lilly Sales Proportion of Insulin API by Product in 2024
 Table 49. Eli Lilly Sales Proportion of Insulin API by Application in 2024
 Table 50. Eli Lilly Sales Proportion of Insulin API by Geographic Area in 2024
 Table 51. Eli Lilly Recent Developments
 Table 52. Tonghua Dongbao Company Information
 Table 53. Tonghua Dongbao Description and Business Overview
 Table 54. Tonghua Dongbao Insulin API Product
 Table 55. Tonghua Dongbao Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 56. Tonghua Dongbao Sales Proportion of Insulin API by Product in 2024
 Table 57. Tonghua Dongbao Sales Proportion of Insulin API by Application in 2024
 Table 58. Tonghua Dongbao Sales Proportion of Insulin API by Geographic Area in 2024
 Table 59. Tonghua Dongbao Recent Developments
 Table 60. Ganlee Company Information
 Table 61. Ganlee Description and Business Overview
 Table 62. Ganlee Insulin API Product
 Table 63. Ganlee Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 64. Ganlee Sales Proportion of Insulin API by Product in 2024
 Table 65. Ganlee Sales Proportion of Insulin API by Application in 2024
 Table 66. Ganlee Sales Proportion of Insulin API by Geographic Area in 2024
 Table 67. Ganlee Recent Developments
 Table 68. United Laboratory Company Information
 Table 69. United Laboratory Description and Business Overview
 Table 70. United Laboratory Insulin API Product
 Table 71. United Laboratory Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 72. United Laboratory Sales Proportion of Insulin API by Product in 2024
 Table 73. United Laboratory Sales Proportion of Insulin API by Application in 2024
 Table 74. United Laboratory Sales Proportion of Insulin API by Geographic Area in 2024
 Table 75. United Laboratory Recent Developments
 Table 76. Biocon Company Information
 Table 77. Biocon Description and Business Overview
 Table 78. Biocon Insulin API Product
 Table 79. Biocon Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 80. Biocon Sales Proportion of Insulin API by Product in 2024
 Table 81. Biocon Sales Proportion of Insulin API by Application in 2024
 Table 82. Biocon Sales Proportion of Insulin API by Geographic Area in 2024
 Table 83. Biocon Recent Developments
 Table 84. Amphastar Company Information
 Table 85. Amphastar Description and Business Overview
 Table 86. Amphastar Insulin API Product
 Table 87. Amphastar Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Amphastar Sales Proportion of Insulin API by Product in 2024
 Table 89. Amphastar Sales Proportion of Insulin API by Application in 2024
 Table 90. Amphastar Sales Proportion of Insulin API by Geographic Area in 2024
 Table 91. Amphastar Recent Developments
 Table 92. Wockhardt Company Information
 Table 93. Wockhardt Description and Business Overview
 Table 94. Wockhardt Insulin API Product
 Table 95. Wockhardt Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 96. Wockhardt Sales Proportion of Insulin API by Product in 2024
 Table 97. Wockhardt Sales Proportion of Insulin API by Application in 2024
 Table 98. Wockhardt Sales Proportion of Insulin API by Geographic Area in 2024
 Table 99. Wockhardt Recent Developments
 Table 100. Julphar Diabetes Company Information
 Table 101. Julphar Diabetes Description and Business Overview
 Table 102. Julphar Diabetes Insulin API Product
 Table 103. Julphar Diabetes Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 104. Julphar Diabetes Sales Proportion of Insulin API by Product in 2024
 Table 105. Julphar Diabetes Sales Proportion of Insulin API by Application in 2024
 Table 106. Julphar Diabetes Sales Proportion of Insulin API by Geographic Area in 2024
 Table 107. Julphar Diabetes Recent Developments
 Table 108. Torrent Pharma Company Information
 Table 109. Torrent Pharma Description and Business Overview
 Table 110. Torrent Pharma Insulin API Product
 Table 111. Torrent Pharma Insulin API Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 112. Torrent Pharma Sales Proportion of Insulin API by Product in 2024
 Table 113. Torrent Pharma Sales Proportion of Insulin API by Application in 2024
 Table 114. Torrent Pharma Sales Proportion of Insulin API by Geographic Area in 2024
 Table 115. Torrent Pharma Recent Developments
 Table 116. North America Insulin API Sales by Country (2020-2025) & (K Units)
 Table 117. North America Insulin API Sales by Country (2026-2031) & (K Units)
 Table 118. North America Insulin API Revenue by Country (2020-2025) & (US$ Million)
 Table 119. North America Insulin API Revenue by Country (2026-2031) & (US$ Million)
 Table 120. North America Insulin API Sales by Type (2020-2025) & (K Units)
 Table 121. North America Insulin API Sales by Application (2020-2025) & (K Units)
 Table 122. Asia-Pacific Insulin API Sales by Region (2020-2025) & (K Units)
 Table 123. Asia-Pacific Insulin API Sales by Region (2026-2031) & (K Units)
 Table 124. Asia-Pacific Insulin API Revenue by Region (2020-2025) & (US$ Million)
 Table 125. Asia-Pacific Insulin API Revenue by Region (2026-2031) & (US$ Million)
 Table 126. Asia-Pacific Insulin API Sales by Type (2020-2025) & (K Units)
 Table 127. Asia-Pacific Insulin API Sales by Application (2020-2025) & (K Units)
 Table 128. Europe Insulin API Sales by Country (2020-2025) & (K Units)
 Table 129. Europe Insulin API Sales by Country (2026-2031) & (K Units)
 Table 130. Europe Insulin API Revenue by Country (2020-2025) & (US$ Million)
 Table 131. Europe Insulin API Revenue by Country (2026-2031) & (US$ Million)
 Table 132. Europe Insulin API Sales by Type (2020-2025) & (K Units)
 Table 133. Europe Insulin API Sales by Application (2020-2025) & (K Units)
 Table 134. Latin America Insulin API Sales by Country (2020-2025) & (K Units)
 Table 135. Latin America Insulin API Sales by Country (2026-2031) & (K Units)
 Table 136. Latin America Insulin API Revenue by Country (2020-2025) & (US$ Million)
 Table 137. Latin America Insulin API Revenue by Country (2026-2031) & (US$ Million)
 Table 138. Latin America Insulin API Sales by Type (2020-2025) & (K Units)
 Table 139. Latin America Insulin API Sales by Application (2020-2025) & (K Units)
 Table 140. Middle East and Africa Insulin API Sales by Country (2020-2025) & (K Units)
 Table 141. Middle East and Africa Insulin API Sales by Country (2026-2031) & (K Units)
 Table 142. Middle East and Africa Insulin API Revenue by Country (2020-2025) & (US$ Million)
 Table 143. Middle East and Africa Insulin API Revenue by Country (2026-2031) & (US$ Million)
 Table 144. Middle East and Africa Insulin API Sales by Type (2020-2025) & (K Units)
 Table 145. Middle East and Africa Insulin API Sales by Application (2020-2025) & (K Units)
 Table 146. Insulin API Key Raw Materials, Industry Status and Trend
 Table 147. Insulin API Key Raw Materials and Upstream Suppliers
 Table 148. Insulin API Clients Status and Trend
 Table 149. Insulin API Typical Clients
 Table 150. Insulin API Distributors
 Table 151. Insulin API Market Trends
 Table 152. Insulin API Market Drivers
 Table 153. Insulin API Market Challenges
 Table 154. Insulin API Market Restraints
 Table 155. Research Programs/Design for This Report
 Table 156. Key Data Information from Secondary Sources
 Table 157. Key Data Information from Primary Sources
 Table 158. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Insulin API Product Picture
 Figure 2. Global Insulin API Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Insulin API Sales Market Share by Type in 2024 & 2031
 Figure 4. Regular Human Insulin Product Picture
 Figure 5. Insulin Analogue Product Picture
 Figure 6. Global Insulin API Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Insulin API Sales Market Share by Application in 2024 & 2031
 Figure 8. Fast-Acting
 Figure 9. Premix
 Figure 10. Long-Acting
 Figure 11. Insulin API Report Years Considered
 Figure 12. Global Insulin API Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Insulin API Market Size 2020-2031 (US$ Million)
 Figure 14. Global Insulin API Sales 2020-2031 (K Units)
 Figure 15. Global Insulin API Sales Market Share Forecast by Region (2020-2031)
 Figure 16. Global Insulin API Revenue Market Share by Region (2020-2031)
 Figure 17. Global Insulin API Sales Market Share Forecast by Type (2020-2031)
 Figure 18. Global Insulin API Revenue Market Share Forecast by Type (2020-2031)
 Figure 19. Insulin API Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
 Figure 20. Global Insulin API Sales Market Share Forecast by Application (2020-2031)
 Figure 21. Global Insulin API Revenue Market Share Forecast by Application (2020-2031)
 Figure 22. Insulin API Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
 Figure 23. Regular Human Insulin of Insulin API Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Insulin Analogue of Insulin API Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Global Insulin API Sales Share by Manufacturer in 2024
 Figure 26. Insulin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 27. Regular Human Insulin Market Sales Proportion by Manufacturer in 2024
 Figure 28. Insulin Analogue Market Sales Proportion by Manufacturer in 2024
 Figure 29. North America Insulin API Revenue 2020-2031 (US$ Million)
 Figure 30. North America Insulin API Sales Market Share by Type (2020-2025)
 Figure 31. North America Insulin API Sales Market Share by Application (2020-2025)
 Figure 32. Asia-Pacific Insulin API Revenue 2020-2031 (US$ Million)
 Figure 33. Asia-Pacific Insulin API Sales Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific Insulin API Revenue Market Share by Region (2020-2031)
 Figure 35. Asia-Pacific Insulin API Sales Market Share by Type (2020-2025)
 Figure 36. Asia-Pacific Insulin API Sales Market Share by Application (2020-2025)
 Figure 37. Europe Insulin API Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 38. Europe Insulin API Sales Market Share by Country (2020-2031)
 Figure 39. Europe Insulin API Revenue Market Share by Country (2020-2031)
 Figure 40. Europe Insulin API Sales Market Share by Type (2020-2025)
 Figure 41. Europe Insulin API Sales Market Share by Application (2020-2025)
 Figure 42. Latin America Insulin API Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 43. Latin America Insulin API Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Insulin API Revenue Market Share by Country (2020-2025)
 Figure 45. Latin America Insulin API Sales Market Share by Type (2020-2025)
 Figure 46. Latin America Insulin API Sales Market Share by Application (2020-2025)
 Figure 47. Middle East and Africa Insulin API Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 48. Middle East and Africa Insulin API Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Insulin API Revenue Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Insulin API Sales Market Share by Type (2020-2025)
 Figure 51. Middle East and Africa Insulin API Sales Market Share by Application (2020-2025)
 Figure 52. Insulin API Supply Chain (Upstream and Downstream Market)
 Figure 53. Global Production Market Share of Insulin API Raw Materials by Region in 2024
 Figure 54. Insulin API Distribution Channels
 Figure 55. Global Insulin API Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 56. Global Insulin API Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Insulin Preparation Market Research Report 2025
Global Insulin Raw Material Market Research Report 2025
Global Animal Insulin Market Insights Forecast to 2030
Global Recombinant Human Insulin Market Insights Forecast to 2030
Global Insulin Drugs for Diabetes Market Research Report 2024
Global Human Insulin Market Research Report 2024
Global Human Insulin Regular Market Research Report 2025
Global Human Recombinant Insulin Market Research Report 2024
Global Human Insulin Drugs Market Research Report 2025
Global Insulin Analog Market Research Report 2025
Veterinary Insulin Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Insulin Management System Market Insights Forecast to 2030
Global Insulin Injection Equipment Market Research Report 2025
Global Fast acting Human Insulin Market Research Report 2024
Global Human Insulin Injections Market Research Report 2024
Global Recombinant Insulin Analogue Market Research Report 2024
Global Long Acting Insulin Analogue Market Research Report 2025
Global Human Insulin Drugs And Delivery Devices Market Insights Forecast to 2030
Global Diabetes Insulin Pen Market Research Report 2024
Global Rapid Acting Insulins Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions